Guselkumab-Treated Patients with Psoriatic Arthritis Achieved Clinically Meaningful Improvements in General Health Outcomes Measured with PROMIS-29 Through 52 Weeks: Results from the Phase 3 DISCOVER-1 Trial

Metadata

Authors/Creators:	Orbai, A-M Coates, L Deodhar, A Helliwell, PS https://orcid.org/0000-0002-4155-9105 Ritchlin, C Kollmeier, A Hsia, E Xu, X Sheng, S Jiang, Y Liu, Y Han, C
Dates:	Published: September 2021
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	05 Aug 2022 12:16
Last Modified:	05 Aug 2022 12:16
Status:	Published
Identification Number:	https://doi.org/10.1002/art.41966
Related URLs:	Author

CORE (COnnecting REpositories)